Gianluca Gaïdano

Research interests

Publications

• International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia

  Blood · 2020 · https://doi.org/10.1182/blood.2019003453

• Tafasitamab plus lenalidomide in relapsed or refractory diffuse large B-cell lymphoma (L-MIND): a multicentre, prospective, single-arm, phase 2 study

  The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30225-4

• Immunogenicity and safety of the adjuvanted recombinant zoster vaccine in adults with haematological malignancies: a phase 3, randomised, clinical trial and post-hoc efficacy analysis

  The Lancet Infectious Diseases · 2019 · https://doi.org/10.1016/s1473-3099(19)30163-x

• ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia—update on methodological approaches and results interpretation

  Leukemia · 2018 · https://doi.org/10.1038/s41375-017-0007-7

• Circulating Tumor DNA Measurements As Early Outcome Predictors in Diffuse Large B-Cell Lymphoma

  Journal of Clinical Oncology · 2018 · https://doi.org/10.1200/jco.2018.78.5246

• Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma

  Blood · 2018 · https://doi.org/10.1182/blood-2017-11-812073

• Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study

  The Lancet Oncology · 2015 · https://doi.org/10.1016/s1470-2045(15)00464-7

• Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

  New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1509388

• Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma

  Cancer Cell · 2015 · https://doi.org/10.1016/j.ccell.2015.03.006

• Genetics of Follicular Lymphoma Transformation

  Cell Reports · 2014 · https://doi.org/10.1016/j.celrep.2013.12.027

• Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: a nationwide retrospective survey from Italy

  Bone Marrow Transplantation · 2014 · https://doi.org/10.1038/bmt.2014.231

• Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

  Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.52.0023

• Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome

  Blood · 2013 · https://doi.org/10.1182/blood-2013-03-489518

• The coding genome of splenic marginal zone lymphoma: activation of NOTCH2 and other pathways regulating marginal zone development

  The Journal of Experimental Medicine · 2012 · https://doi.org/10.1084/jem.20120904

• Inactivating mutations of acetyltransferase genes in B-cell lymphoma

  Nature · 2011 · https://doi.org/10.1038/nature09730

• Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation

  The Journal of Experimental Medicine · 2011 · https://doi.org/10.1084/jem.20110921

• Analysis of the coding genome of diffuse large B-cell lymphoma

  Nature Genetics · 2011 · https://doi.org/10.1038/ng.892

• The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation

  Blood · 2011 · https://doi.org/10.1182/blood-2010-09-302174

• Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

  Blood · 2010 · https://doi.org/10.1182/blood-2010-07-294983

• Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome

  Blood · 2010 · https://doi.org/10.1182/blood-2010-01-264275

• Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome

  Clinical Cancer Research · 2009 · https://doi.org/10.1158/1078-0432.ccr-08-3266

• The dynamic DNA methylomes of double-stranded DNA viruses associated with human cancer

  Genome Research · 2009 · https://doi.org/10.1101/gr.083550.108

• Genomic and expression profiling identifies the B‐cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma

  British Journal of Haematology · 2005 · https://doi.org/10.1111/j.1365-2141.2005.05883.x

• Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus Type 8-Positive Solid Lymphomas

  Journal of Molecular Diagnostics · 2005 · https://doi.org/10.1016/s1525-1578(10)60004-9

• Expression profile of MUM1/IRF4, BCL-6, and CD138/syndecan-1 defines novel histogenetic subsets of human immunodeficiency virus–related lymphomas

  Blood · 2001 · https://doi.org/10.1182/blood.v97.3.744

• Distribution and pattern of BCL-6 mutations throughout the spectrum of B-cell neoplasia.

  PubMed · 2000 · https://doi.org/10.1182/blood.v95.2.651

• The molecular and phenotypic profile of primary central nervous system lymphoma identifies distinct categories of the disease and is consistent with histogenetic derivation from germinal center-related B cells.

  PubMed · 1998 · https://doi.org/10.1182/blood.v92.3.1011

• Kaposi's sarcoma‐associated herpesvirus DNA sequences in AIDS‐related and AIDS‐unrelated lymphomatous effusions

  British Journal of Haematology · 1996 · https://doi.org/10.1046/j.1365-2141.1996.d01-1826.x

• p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia.

  Proceedings of the National Academy of Sciences · 1991 · https://doi.org/10.1073/pnas.88.12.5413

Current projects

No projects listed.